BioCardia, Inc. (BCDA) shareholders
BCDANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.83−0.10 (-10.38%)
Close on Nov 12, 2026Market cap $12.50MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
8.8%
1M of 15M shares
Institutional holders
21
8 new, 5 sold out
Net institutional buying
1M
In Q2 2026
Insider trades, 12 months
34 buys · 0 sales
Net bought $169.64K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Thomas A. Satterfield, Jr. | 1,539,134 | 9.90% | 13G (passive) amendment | Sep 30, 2026 |
| Lincoln Alternative Strategies LLC | 800,000 | 7.54% | 13G (passive) | Sep 19, 2025 |
| Blank Andrew Scott | 278,253 | 5.50% | 13D (active) | Apr 23, 2025 |
| Daly Joseph Patrick | – | – | 13D (active) amendment | May 14, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of BCDA | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Citigroup Inc | 397,594 | 2.63% | $493.02K | New | 0.00% |
| CM Management, LLC | 300,000 | 1.98% | $372.00K | +170,000 | 0.25% |
| Vanguard Capital Management LLC | 124,591 | 0.82% | $154.49K | – | 0.00% |
| Pingora Partners LLC | 120,382 | 0.80% | $149.27K | +84,643 | 0.09% |
| UBS Group AG | 77,619 | 0.51% | $96.25K | New | 0.00% |
| Geode Capital Management, LLC | 66,664 | 0.44% | $82.66K | −27,623 | 0.00% |
| Vanguard Fiduciary Trust Co | 66,270 | 0.44% | $82.18K | – | 0.00% |
| Susquehanna International Group, Llp | 38,809 | 0.26% | $48.12K | −18 | 0.00% |
| Brown Advisory Inc | 35,538 | 0.23% | $44.07K | – | 0.00% |
| Commonwealth Equity Services, LLC | 23,383 | 0.15% | $28.99K | +5,100 | 0.00% |
| Citadel Advisors LLC | 22,956 | 0.15% | $28.47K | −40,428 | 0.00% |
| StoneX Group Inc. | 20,020 | 0.13% | $24.83K | New | 0.00% |
| Wealth Enhancement Advisory Services, LLC | 18,500 | 0.12% | $16.92K | New | 0.00% |
| Gsa Capital Partners Llp | 12,862 | 0.08% | $16.00K | New | 0.00% |
| Tower Research Capital LLC (TRC) | 3,187 | 0.02% | $3.95K | +209 | 0.00% |
| Morgan Stanley | 3,105 | 0.02% | $3.85K | – | 0.00% |
| Allied Private Wealth LLC | 1,449 | 0.01% | $1.40K | New | 0.00% |
| Global Retirement Partners, LLC | 411 | 0.00% | $510 | New | 0.00% |
| SBI Securities Co., Ltd. | 9 | 0.00% | $11 | – | 0.00% |
| Osaic Holdings, Inc. | 1 | 0.00% | $1 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 21 | 1M | 8.8% | 8 / 4 | 3 / 5 | 1M | 0M |
| Q1 2026 | 18 | 1M | 4.5% | 6 / 5 | 2 / 6 | 0M | 0M |
| Q4 2025 | 20 | 1M | 4.3% | 4 / 8 | 3 / 2 | 0M | 0M |
| Q3 2025 | 18 | 0M | 2.8% | 5 / 5 | 1 / 3 | 0M | 0M |
| Q2 2025 | 16 | 0M | 2.0% | 4 / 4 | 3 / 0 | 0M | 0M |
| Q1 2025 | 12 | 0M | 1.6% | 2 / 5 | 3 / 2 | 0M | 0M |
| Q4 2024 | 13 | 0M | 0.8% | 4 / 2 | 3 / 0 | 0M | 0M |
| Q3 2024 | 9 | 0M | 0.7% | 1 / 3 | 1 / 1 | 0M | 0M |
| Q2 2024 | 9 | 0M | 0.5% | 9 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
7 funds held BCDA in Q2 2026, 63% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of BCDA | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 69,023 | 0.46% | $85.59K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 59,971 | 0.40% | $55.77K | 0.00% | May 31, 2026 |
| Vanguard Total Stock Market Index Fund | 55,568 | 0.37% | $68.90K | 0.00% | Jun 30, 2026 |
| Fidelity Series Total Market Index Fund | 10,526 | 0.07% | $9.79K | 0.00% | May 31, 2026 |
| Fidelity Total Market Index Fund | 3,237 | 0.02% | $3.01K | 0.00% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 964 | 0.01% | $897 | 0.00% | May 31, 2026 |
| Blackstone Alternative Multi-Strategy Fund | 47 | 0.00% | $58 | 0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Peter Altman | President and CEO, Director | 385,385 | 2.55% | Oct 20, 2026 |
| Edward M. Gillis | Senior Vice President, Devices | 54,126 | 0.36% | Jul 7, 2026 |
| David McClung | Chief Financial Officer | 114,245 | 0.75% | Jul 7, 2026 |
| Simon H. Stertzer | Director | 225,542 | 1.49% | Jul 7, 2026 |
| Jim L. Allen | Director | 109,667 | 0.72% | Jul 7, 2026 |
| Bill Facteau | Director | 13,123 | 0.09% | Jul 7, 2026 |
| Jay M. Moyes | Director | 213,276 | 1.41% | Jul 7, 2026 |
| Marvin Slosman | Director | – | – | Jul 7, 2026 |
| Andrew Scott Blank | Director | 636,058 | 4.20% | Jul 7, 2026 |
| Richard M. Krasno | Director | 16,268 | 0.11% | Apr 28, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Peter Altman President and CEO, Director | Oct 16, 2026 | Buy | +300 | $0.95 | $285 | 385,385 |
| Peter Altman President and CEO, Director | Oct 15, 2026 | Buy | +200 | $0.95 | $190 | 385,085 |
| Peter Altman President and CEO, Director | Sep 29, 2026 | Buy | +1,000 | $1.03 | $1.03K | 384,885 |
| Peter Altman President and CEO, Director | Sep 23, 2026 | Buy | +1,900 | $1.05 | $2.00K | 383,885 |
| Peter Altman President and CEO, Director | Sep 3, 2026 | Buy | +800 | $1.09 | $872 | 381,985 |
| Peter Altman President and CEO, Director | Aug 17, 2026 | Buy | +5,400 | $0.93 | $5.02K | 381,115 |
| Peter Altman President and CEO, Director | Aug 13, 2026 | Buy | +1,900 | $0.92 | $1.75K | 375,785 |
| Peter Altman President and CEO, Director | Jul 29, 2026 | Buy | +5,000 | $0.78 | $3.90K | 373,885 |
| Peter Altman President and CEO, Director | Jul 17, 2026 | Buy | +500 | $0.83 | $415 | 368,885 |
| Peter Altman President and CEO, Director | Jul 15, 2026 | Buy | +1,500 | $0.86 | $1.29K | 368,385 |
| Peter Altman President and CEO, Director | Jul 14, 2026 | Buy | +2,800 | $0.88 | $2.46K | 366,885 |
| Peter Altman President and CEO, Director | Jul 10, 2026 | Buy | +1,000 | $0.94 | $940 | 369,485 |
| Peter Altman President and CEO, Director | Jul 9, 2026 | Buy | +1,000 | $0.90 | $900 | 368,485 |
| Peter Altman President and CEO, Director | Jul 8, 2026 | Buy | +5,500 | $0.97 | $5.34K | 367,485 |
| Peter Altman President and CEO, Director | Jul 8, 2026 | Buy | +5,400 | $0.96 | $5.18K | 361,985 |
| Peter Altman President and CEO, Director | Jul 2, 2026 | Tax withholding | −54,606 | $1.24 | $67.71K | 356,585 |
| David McClung Chief Financial Officer | Jul 2, 2026 | Tax withholding | −23,125 | $1.24 | $28.68K | 114,245 |
| Edward M. Gillis Senior Vice President, Devices | Jul 2, 2026 | Tax withholding | −17,269 | $1.24 | $21.41K | 54,126 |
| Edward M. Gillis Senior Vice President, Devices | Jun 29, 2026 | Award | +39,521 | $1.20 | $47.43K | 71,395 |
| Peter Altman President and CEO, Director | Jun 29, 2026 | Award | +110,625 | $1.20 | $132.75K | 411,191 |
| David McClung Chief Financial Officer | Jun 29, 2026 | Award | +60,483 | $1.20 | $72.58K | 137,370 |
| Simon H. Stertzer Director | Jun 23, 2026 | Buy | +39,000 | $1.00 | $39.00K | 166,338 |
| Simon H. Stertzer Director | Jun 22, 2026 | Buy | +70,200 | $0.92 | $64.58K | 127,338 |
| Peter Altman President and CEO, Director | Jun 18, 2026 | Buy | +800 | $0.96 | $768 | 300,566 |
| Peter Altman President and CEO, Director | Jun 17, 2026 | Buy | +1,500 | $0.85 | $1.28K | 299,766 |
| Peter Altman President and CEO, Director | Jun 9, 2026 | Buy | +5,000 | $0.85 | $4.25K | 298,266 |
| Peter Altman President and CEO, Director | May 20, 2026 | Buy | +1,500 | $0.92 | $1.38K | 293,266 |
| Peter Altman President and CEO, Director | May 19, 2026 | Buy | +200 | $0.95 | $190 | 291,766 |
| Peter Altman President and CEO, Director | May 18, 2026 | Buy | +5,700 | $0.92 | $5.24K | 291,566 |
| Peter Altman President and CEO, Director | May 15, 2026 | Buy | +5,100 | $1.02 | $5.20K | 285,866 |
| Peter Altman President and CEO, Director | Apr 29, 2026 | Buy | +5,000 | $1.11 | $5.55K | 280,766 |
| Peter Altman President and CEO, Director | Apr 21, 2026 | Buy | +400 | $1.23 | $492 | 275,766 |
| Peter Altman President and CEO, Director | Apr 20, 2026 | Buy | +600 | $1.23 | $738 | 275,366 |
| Peter Altman President and CEO, Director | Mar 25, 2026 | Buy | +300 | $1.22 | $366 | 274,766 |
| Peter Altman President and CEO, Director | Mar 24, 2026 | Buy | +600 | $1.24 | $744 | 274,466 |
| Peter Altman President and CEO, Director | Feb 4, 2026 | Buy | +5,000 | $1.13 | $5.65K | 273,866 |
| Peter Altman President and CEO, Director | Jan 21, 2026 | Buy | +300 | $1.34 | $402 | 268,866 |
| Peter Altman President and CEO, Director | Jan 20, 2026 | Buy | +600 | $1.32 | $792 | 268,566 |
| Peter Altman President and CEO, Director | Dec 17, 2025 | Buy | +900 | $1.30 | $1.17K | 267,966 |
| Peter Altman President and CEO, Director | Dec 16, 2025 | Buy | +200 | $1.37 | $274 | 267,066 |
| Edward M. Gillis Senior Vice President, Devices | Dec 8, 2025 | Tax withholding | +15,172 | $1.37 | $20.79K | 31,874 |
| Edward M. Gillis Senior Vice President, Devices | Dec 8, 2025 | Award | +38,078 | $1.37 | $52.17K | 47,046 |
| Peter Altman President and CEO, Director | Dec 8, 2025 | Award | +106,588 | $1.37 | $146.03K | 323,350 |
| Peter Altman President and CEO, Director | Dec 8, 2025 | Tax withholding | +56,484 | $1.37 | $77.38K | 266,866 |
| David McClung Chief Financial Officer | Dec 8, 2025 | Award | +58,276 | $1.37 | $79.84K | 106,226 |
| David McClung Chief Financial Officer | Dec 8, 2025 | Tax withholding | +29,339 | $1.37 | $40.19K | 76,887 |
| Simon H. Stertzer Director | Sep 19, 2025 | Buy | +398,400 | $1.25 | $498.00K | 591,054 |
| Andrew Scott Blank Director | Sep 19, 2025 | Buy | +288,000 | $1.25 | $360.00K | 634,023 |
| Peter Altman President and CEO, Director | Sep 19, 2025 | Buy | +48,000 | $1.25 | $60.00K | 216,762 |
| Peter Altman President and CEO, Director | Aug 22, 2025 | Buy | +700 | $1.83 | $1.28K | 168,762 |
| Peter Altman President and CEO, Director | Aug 13, 2025 | Buy | +100 | $1.83 | $183 | 168,062 |
| Peter Altman President and CEO, Director | Aug 12, 2025 | Buy | +400 | $1.75 | $700 | 167,962 |
| Peter Altman President and CEO, Director | Aug 11, 2025 | Buy | +1,700 | $1.76 | $2.99K | 167,562 |
| Andrew Scott Blank Director | Jun 30, 2025 | Buy | +72,289 | $2.08 | $150.36K | 346,023 |
| Peter Altman President and CEO, Director | Jun 30, 2025 | Buy | +24,096 | $2.08 | $50.12K | 165,862 |
| David McClung Chief Financial Officer | Jun 30, 2025 | Buy | +4,819 | $2.08 | $10.02K | 47,950 |
| Simon H. Stertzer Director | Jun 30, 2025 | Buy | +72,289 | $2.08 | $150.36K | 192,654 |
| Peter Altman President and CEO, Director | May 30, 2025 | Buy | +100 | $2.21 | $221 | 141,766 |
| Peter Altman President and CEO, Director | May 22, 2025 | Buy | +700 | $1.89 | $1.32K | 141,666 |
| Peter Altman President and CEO, Director | May 20, 2025 | Buy | +1,600 | $2.08 | $3.33K | 140,966 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of float
5.50%
1M shares short
Days to cover
6.3
At 0M shares a day
Change since last report
+8.4%
From 1M shares
Short volume, 20 days
51.1%
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of BioCardia's stock actually held short. Settlement fails (shares not delivered on time) peaked at 96,090 shares on Sep 22, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Edward M. Gillis Officer | Dec 17, 2024 | 3,257 | $6.61K | Dec 17, 2024 | Restricted Stock Units |
See a number that looks wrong?